FibroBiologics Investor Day Webinar - Regenerative Medicine

FibroBiologics presented their investor day webinar focused on leveraging fibroblast immune modulation and regenerative potential to treat chronic diseases. The company showcases their mission to become a world leader in regenerative medicine with 108 issued patents and 48 pending patent applications.